Kellie Yarnell

Kellie Yarnell is vice president of genomics laboratories, where she leads our genomics efforts and organization. Previously, Kellie led genomic operations for Expression Analysis, an organization specializing in next-generation sequencing and bioinformatics services supporting the biopharmaceutical clinical trial and research market. Kellie brings more than 15 years of commercial expertise, scientific aptitude and strategic vision in the genomics space to the organization.

Kellie earned a Bachelor of Science in Biochemistry from the University of Delaware.